Infectious disease test kit

oncologyCOVID-19genetic

RT-PCR with CRISPR Advantage: Tata MD CHECK RT-PCR CRISPR is a world-class diagnostic test for COVID-19, based on FELUDA, a CRISPR Cas-9 based technology proven and popular in genetic engineering medicine. Broad Application The CRISPR Cas-9 platform underlying Tata MD CHECK can be easily extended to many applications in molecular testing, e.g. infectious diseases, oncology and new-born diagnostics. FELUDA is developed indigenously by CSIR-IGIB, a leading Indian biosciences research institute. Tata MD CHECK RT-PCR CRISPR test uses Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for the Amplification process and CRISPR-Cas9 technology to detect SARS-CoV-2 nucleic acids (RNA) in human samples.Diagnostic Internationally Approved India: Approved by DCGI as per ICMR guidelines Europe: Tata MD CHECK is CE certified. Legally commercialised in the European Union